Search results for "led"

showing 10 items of 8768 documents

Supraglottic airway devices for surfactant treatment: systematic review and meta-analysis

2019

Objective: To compare surfactant administration via supraglottic airway device (SAD) vs. nasal CPAP alone or INSURE. Study design: A systematic search of PubMed, EMBASE, SCOPUS, Cochrane Central Register of Controlled Trials and Clinicaltrials.gov was performed. Articles meeting inclusion criteria (RCT, surfactant administration via SAD, laryngeal mask, I-gel) were assessed Results: Five RCTs were eligible. Surfactant administration via SAD reduced the need for intubation/mechanical ventilation (RR 0.57, 95%CI 0.38–0.85) and short-term oxygen requirements (MD −8.00, 95%CI −11.09 to −4.91) compared to nCPAP alone. Surfactant administration via SAD reduced the need for intubation/mechanical v…

medicine.medical_treatmentLaryngeal Maskslaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPulmonary surfactantlaw030225 pediatricsmedicineIntubation IntratrachealIntubationHumans030212 general & internal medicineRandomized Controlled Trials as TopicMechanical ventilationSupraglottic airwayRespiratory Distress Syndrome Newbornbusiness.industryInfant NewbornObstetrics and GynecologyPulmonary SurfactantsSupraglottic airwayRespiration ArtificialClinical trialLaryngeal MasksMeta-analysisAnesthesiaPediatrics Perinatology and Child Healthsurfactant treatmentbusinessInfant Premature
researchProduct

Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo

2012

Abstract Introduction Bisphosphonates are important and effective drugs in oncology and osteoporosis therapy. They accumulate in the bone matrix becoming released and active by bone resorption. This leads to effective inhibition of tumor cells and bone degradation. A side effect of bisphosphonates similar to other drugs like denosumab is osteonecrosis of the jaws (ONJ). This problem mostly occurs after tooth extraction. We studied the cytoprotectant dexrazoxane known from anthracycline chemotherapy for cytoprotection in nitrogen-containing bisphosphonate treated cells and in the rabbit tibia model to evaluate a possible value in ONJ management. Materials & methods Human osteoblasts (HOB) P2…

medicine.medical_treatmentOsteoporosisCell Culture TechniquesGingivaTetrazolium SaltsApoptosisPharmacologyCell morphologyZoledronic AcidOsteogenesisColoring AgentsDrug CarriersBone Density Conservation AgentsDiphosphonatesImidazolesFluoresceinsResorptionDenosumabModels AnimalFemaleCollagenRabbitsOral SurgeryRazoxanemedicine.drugmedicine.medical_specialtyCell SurvivalProtective AgentsBone resorptionCell LinemedicineAnimalsHumansBone ResorptionCell ShapeFluorescent DyesOsteoblastsTibiabusiness.industryFibroblastsBisphosphonatemedicine.diseaseSurgeryThiazolesDurapatiteZoledronic acidOtorhinolaryngologyCytoprotectionSurgeryDexrazoxanebusinessJournal of Cranio-Maxillofacial Surgery
researchProduct

Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes

2018

The following article: Jung, R.E., Al-Nawas, B., Araujo, M., Avila-Ortiz, G., Barter, S., Brodala, N., ... Windisch, P. (2018). Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes. Clinical Oral Implants Research, 29(S16), 69-77, can be accessed at https://doi.org/10.1111/clr.13342. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Objectives: The aim of Working Group 1 was to address the influence of different local (implant length, diameter, and design) and systemic (medications) factors on clinical, radiographic, and patient‐re…

medicine.medical_treatmentOsteoporosisbiological complicationsDentistryOsteoporosis/complicationsmeta-analysilaw.inventionProton Pump Inhibitors/adverse effects0302 clinical medicineRandomized controlled triallawRadiography DentalDental Restoration FailureDental implanthumans610 Medicine & healthclinical decision-makingdental implantDiphosphonatesnarrow diameter3504 Oral SurgeryJaw Edentulous Partially05 social sciencesDental Implantation EndosseousImplant failuredrugsmall dental implantVDP::Medisinske Fag: 700::Klinisk odontologiske fag: 830failureclinical decision‐makingDiphosphonates/adverse effectsMeta-analysisrandomized controlled trials/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingepidemiologymedicationOral SurgerySelective Serotonin Reuptake InhibitorsConsensusreview610 Medicine & healthsurvival03 medical and health sciences10068 Clinic of Reconstructive DentistrySDG 3 - Good Health and Well-beingdental implants0502 economics and businessmedicineshort dental implantsHumansbiological complicationPatient Reported Outcome MeasureshumanSurvival ratesmall dental implantsDental Implantsbusiness.industryJaw Edentulous Partially/rehabilitationshort dental implantProton Pump Inhibitors030206 dentistrymedicine.diseaseendosseous implantSurvival AnalysisVDP::Medical disciplines: 700::Clinical dentistry disciplines: 830Dental Prosthesis Designmeta‐analysisRelative riskrandomized controlled trialOsteoporosis050211 marketingImplantSerotonin Uptake Inhibitors/adverse effectsbusinessosteotomySystematic Reviews as Topic
researchProduct

Evaluation of the Oxiris Membrane in Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation Support: Study Protocol for a Single Center, Sin…

2021

Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is the rescue treatment proposed to patients with refractory cardiogenic shock. The VA-ECMO implantation promotes inflammation and ischemia-reperfusion injuries through the VA-ECMO flow, causing digestive mucosa barrier disrupture and inducing translocation of bacterial wall components—Lipopolysaccharides (LPS) with further inflammation and circulatory impairment. LPS is a well-studied surrogate indicator of bacterial translocation. Oxiris membrane is a promising and well-tolerated device that can specifically remove LPS. The main study aim is to compare the LPS elimination capacity of Oxiris membrane vs. a non-absorban…

medicine.medical_treatmentcontinuous renal replacement therapyheart failureoxirisContext (language use)InflammationCardiovascular Medicineartificial membranelaw.inventionStudy ProtocolRandomized controlled triallawmedicineClinical endpointExtracorporeal membrane oxygenationDiseases of the circulatory (Cardiovascular) systemRenal replacement therapycytokines/bloodbusiness.industryCardiogenic shockcardiogenic shockextracorporeal membrane oxygenationmedicine.diseasesurgical procedures operativeendotoxin/bloodRC666-701AnesthesiaHeart failuremedicine.symptomCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct

Mid- to Long-Term Outcomes of Cervical Disc Arthroplasty versus Anterior Cervical Discectomy and Fusion for Treatment of Symptomatic Cervical Disc Di…

2015

Purpose This study aimed to investigate the mid- to long-term outcomes of cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) for the treatment of 1-level or 2-level symptomatic cervical disc disease. Methods Medline, Embase, and the Cochrane Central Register of Controlled Trials databases were searched to identify relevant randomized controlled trials that reported mid- to long-term outcomes (at least 48 months) of CDA versus ACDF. All data were analyzed by Review Manager 5.3 software. The relative risk (RR) and 95% confidence intervals (CIs) were calculated for dichotomous variables. The weighted mean difference (WMD) and 95%CIs were calculated for conti…

medicine.medical_treatmentlcsh:MedicineAnterior cervical discectomy and fusionIntervertebral Disc Degenerationlaw.inventionDatabase and Informatics MethodsMathematical and Statistical Techniques0302 clinical medicineRandomized controlled triallawMedicine and Health SciencesDatabase Searchinglcsh:ScienceRandomized Controlled Trials as Topic030222 orthopedicsMultidisciplinaryResearch AssessmentTreatment Outcomemedicine.anatomical_structureResearch DesignMeta-analysisPhysical SciencesCervical VertebraeIntervertebral Disc DisplacementStatistics (Mathematics)DiskectomyResearch ArticleCervical vertebraemedicine.medical_specialtyDrug Research and DevelopmentSystematic ReviewsClinical Research DesignVisual analogue scaleSurgical and Invasive Medical ProceduresResearch and Analysis MethodsArthroplasty03 medical and health sciencesMusculoskeletal System ProceduresDiscectomyConfidence IntervalsmedicineHumansClinical TrialsStatistical MethodsPharmacologybusiness.industrylcsh:RArthroplastyRandomized Controlled TrialsSurgeryRelative risklcsh:QAdverse EventsClinical MedicinebusinessMathematics030217 neurology & neurosurgeryMeta-AnalysisPLoS ONE
researchProduct

Pharmacokinetics of new oral anticoagulants: implications for use in routine care

2018

Introduction: Since 2008, new oral anticoagulants (NOACs) have been approved for the prevention of venous thromboembolism (VTE) in patients receiving hip or knee replacement surgery, prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE). Premarketing randomized clinical trials (RCTs) of NOACs demonstrated their non-inferiority in terms of efficacy vs. warfarin (traditional oral anticoagulant–TOA), with lower risk of serious adverse drug reactions, especially cerebral hemorrhages. In clinical practice, pharmacokinetic aspects of NOACs have to be carefully taken into account to …

medicine.medical_treatmentnew oral anticoagulantsAdministration OralKnee replacement030204 cardiovascular system & hematologyToxicologyAdherence Bleeding Interactions New oral anticoagulants Over- and under-dosage Persistence Pharmacokinetics Real World Evidence0302 clinical medicineAtrial Fibrillationover- and underdosage030212 general & internal medicinepharmacokineticStrokeRoutine careRandomized Controlled Trials as Topicnew oral anticoagulantAtrial fibrillationpersistenceVenous ThromboembolismGeneral MedicinePulmonary embolismStrokepharmacokineticsHumanmusculoskeletal diseasesmedicine.medical_specialtyinteractionHemorrhageMedication Adherence03 medical and health sciencesPharmacokineticsmedicineHumansReal World EvidenceIn patientOver- and under-dosagecardiovascular diseasesreal-world evidenceIntensive care medicineAgedPharmacologybusiness.industryAnticoagulantAnticoagulantsinteractionsbleedingmedicine.diseaseAdherencePulmonary EmbolismbusinessVenous thromboembolismExpert Opinion on Drug Metabolism & Toxicology
researchProduct

Gas-phase ion chemistry of protonated melatonin

2005

The gas-phase ion chemistry of protonated melatonin has been investigated by mass spectrometric (MS) techniques involving chemical ionisation, fast atom bombardment and electrospray ionisation. Either naturally- occurring or collision-induced decomposition e-D derivatives obtained by exchange with D(2)O. The analysis of experimental results allows definite pathways for the formation of the ion at m/z 174 to be assigned and sheds some more light on the overall fragmentation pathways. Experiments on labelled derivatives evidenced H-D scrambling processes during fragmentation

melatonin ESI/MS ESI/MS/MS deuterium labelled compounds ion chemistry scrambling reactions proton affinitySettore CHIM/02 - Chimica Fisica
researchProduct

Salesperson adoption and usage of mobile sales configuration tools

2018

PurposeThe purpose of this paper is to examine salespersons’ adoption and usage of mobile sales configuration tools (MSCT) and to identify areas for further development in this realm. Another objective is to offer a conceptualization of MSCT adoption.Design/methodology/approachFor this purpose, a qualitative case study approach was selected as the research method to better understand acceptance of a mobile configuration tool used by business-to-business (B2B) salespersons. Primary data were collected through semi-structured interviews, which included a series of open-ended questions to gain more detailed and contextual data.FindingsThe results obtained from the interviews indicated several …

menekkiFuture studiesKnowledge managementGeneral Computer ScienceComputer sciencemyyntimobiilimarkkinointisales force automation0502 economics and businessRealmSocial mediaB2B salesResearch methodSocial desirabilityyritysmyyntiConceptualizationbusiness.industry05 social sciencesmobliililaitteetmobile sales adoptionSales force automationQuantitative analysis (finance)qualitativeion tools050211 marketingbusiness050203 business & managementInformation SystemsJournal of Systems and Information Technology
researchProduct

A Group Intervention to Promote Resilience in Nursing Professionals: A Randomised Controlled Trial

2022

In this study, a new group intervention program to foster resilience in nursing professionals was tested for efficacy. In total, 72 nurses were recruited and randomised to either an intervention condition or to a wait list control condition. The study had a pre-test, post-test, follow-up design. The eight-week program targeted six resilience factors: cognitive flexibility, coping, self-efficacy, self-esteem, self-care, and mindfulness. Compared to the control group, the intervention group reported a significant improvement in the primary outcome mental health (measured with the General Health Questionnaire) from pre-test (M = 20.79; SD = 9.85) to post-test (M = 15.81; SD = 7.13) with an est…

mental health; resilience; nursing; occupational stress; psychotherapy; coping; randomised controlled trialHealth Toxicology and MutagenesisRPublic Health Environmental and Occupational HealthResilience Psychologicalresilience ; mental health ; nursing ; occupational stress ; coping ; randomised controlled trial ; psychotherapySelf EfficacyArticlepsychotherapycopingMental HealthnursingMedicineHumansMindfulnessresiliencerandomised controlled trialoccupational stressRetrospective StudiesInternational Journal of Environmental Research and Public Health
researchProduct

External knowledge sourcing for R&D activities: antecedents and implications of governance mode choice

2014

This paper investigates how internal and external factors affect the choice between alliances and joint ventures (A&JVs) and mergers and acquisitions (M&As) for the external sourcing of research and development (R&D) activities, and whether or not such a choice is really con- tingent, that is, is it the best choice in terms of its impact on firms’ innovative performance under those circumstances? We build a set of hypotheses based on both the transaction-cost theory and the resource-based view, and test them through a secondary data source analy- sis. We found that companies adopt either R&D M&A or A&JV depending on internal (e.g. resources and capabilities, innovation experience) and exter…

mergers and acquisi- tioninnovative performanceStrategy and ManagementCorporate governanceexternal knowledge sourcingManagement Science and Operations ResearchContingency approachSettore ING-IND/35 - Ingegneria Economico-GestionaleAffect (psychology)Test (assessment)contingency approachResource (project management)alliances and joint ventureMergers and acquisitionsBusinessMarketingMode choiceSet (psychology)Industrial organizationTechnology Analysis & Strategic Management
researchProduct